Effect of Silymarin in prevention of contrast nephropaty

Phase 2

• Conditions: ephropathy.; Nephropathy induced by other drugs, medicaments and biological substances

• Registration Number: IRCT2014051117648N1
• Lead Sponsor: Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

having chronic stable angina; indication of coronary angiograghy; willingness to participate.

Exclusion criteria: FBS >=100; eGFR < 60 cc/1.73m2; history of diabetes or kidney disease; having myocardial infarction, unstable angina, or cardiogenic shock; tacking contrast agent during one month before study.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Contrast induced nephropathy. Timepoint: 48 hours after angiography. Method of measurement: Measuring serum creatinine level.

Secondary Outcome Measures

Name	Time	Method
-. Timepoint: -. Method of measurement: -.